Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heart rhythm refers to the coordinated sequence of electrical impulses and subsequent mechanical contractions of the heart muscle required to pump blood effectively throughout the body (StatPearls, NBK534864) [1]. It is a complex physiological process rather than a single molecular target, such as a receptor or enzyme. The rhythm is initiated by specialized pacemaker cells in the sinoatrial node and travels through a dedicated conduction system involving the atrioventricular node and Purkinje fibers (NIH, Heart Contraction and Blood Flow) [2]. Dysregulation of this process leads to cardiac arrhythmias, which are a major cause of morbidity and mortality worldwide. While heart rhythm itself is not a target, it is modulated by drugs that target specific ion channels (e.g., SCN5A, KCNH2) and G protein-coupled receptors (e.g., ADRB1) to restore normal sinus rhythm or control heart rate (PubMed, PMC4212347) [3].
Pharmacological agents modulate heart rhythm by acting on specific molecular targets such as voltage-gated sodium (Nav1.5), potassium (hERG), and calcium channels (L-type), or by modulating autonomic input via beta-adrenergic and muscarinic receptors.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heart rhythm.